Cargando…
Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing
PURPOSE: Gallbladder sarcomatoid carcinoma is a rare cancer with no clinical standard treatment. With the rapid development of next generation sequencing, it has been able to provide reasonable treatment options for patients based on genetic variations. However, most cancer drugs are not approval fo...
Autores principales: | Feng, Feiling, Cheng, Qingbao, Yang, Liang, Zhang, Dadong, Ji, Shunlong, Zhang, Qiangzu, Lin, Yihui, Li, Fugen, Xiong, Lei, Liu, Chen, Jiang, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354913/ https://www.ncbi.nlm.nih.gov/pubmed/28029662 http://dx.doi.org/10.18632/oncotarget.14146 |
Ejemplares similares
-
Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma
por: Feng, Feiling, et al.
Publicado: (2021) -
Establishment and characterization of patient-derived primary cell lines as preclinical models for gallbladder carcinoma
por: Feng, Feiling, et al.
Publicado: (2020) -
Adenosquamous Carcinoma of the Gallbladder With Sarcomatoid Features
por: Majeed, Nasma K., et al.
Publicado: (2020) -
Sarcomatoid carcinoma of the gallbladder: A rare form of gallbladder
cancer
por: Siddiqui, Mehdi, et al.
Publicado: (2020) -
Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder
por: Liu, Fatao, et al.
Publicado: (2021)